File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1038/s41375-022-01606-0
- Scopus: eid_2-s2.0-85130800255
- WOS: WOS:000805485900002
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Regulation of proton partitioning in kinase-activating acute myeloid leukemia and its therapeutic implication
Title | Regulation of proton partitioning in kinase-activating acute myeloid leukemia and its therapeutic implication |
---|---|
Authors | |
Issue Date | 27-May-2022 |
Publisher | Springer Nature [academic journals on nature.com] |
Citation | Leukemia, 2022, v. 36, p. 1990-2001 How to Cite? |
Abstract | Gain-of-function kinase mutations are common in AML and usually portend an inferior prognosis. We reported a novel mechanism whereby kinase mutants induced intracellular alkalization characteristic in oncogenesis. Thirteen kinases were found to activate sodium/hydrogen exchanger (NHE1) in normal hematopoietic progenitors, of which FLT3-ITD, KRASG12D, and BTK phosphorylated NHE1 maintained alkaline intracellular pH (pHi) and supported survival of AML cells. Primary AML samples with kinase mutations also showed increased NHE1 phosphorylation and evidence of NHE1 addiction. Amiloride enhanced anti-leukemic effects and intracellular distribution of kinase inhibitors and chemotherapy. Co-inhibition of NHE1 and kinase synergistically acidified pHi in leukemia and inhibited its growth in vivo. Plasma from patients taking amiloride for diuresis reduced pHi of leukemia and enhanced cytotoxic effects of kinase inhibitors and chemotherapy in vitro. NHE1-mediated intracellular alkalization played a key pathogenetic role in transmitting the proliferative signal from mutated-kinase and could be exploited for therapeutic intervention in AML. |
Persistent Identifier | http://hdl.handle.net/10722/338944 |
ISSN | 2023 Impact Factor: 12.8 2023 SCImago Journal Rankings: 3.662 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Man, CH | - |
dc.contributor.author | Zeng, XY | - |
dc.contributor.author | Lam, W | - |
dc.contributor.author | Ng, TCC | - |
dc.contributor.author | Kwok, TH | - |
dc.contributor.author | Dang, KCC | - |
dc.contributor.author | Leung, TWY | - |
dc.contributor.author | Ng, NKL | - |
dc.contributor.author | Lam, SSY | - |
dc.contributor.author | Cher, CY | - |
dc.contributor.author | Leung, AYH | - |
dc.date.accessioned | 2024-03-11T10:32:43Z | - |
dc.date.available | 2024-03-11T10:32:43Z | - |
dc.date.issued | 2022-05-27 | - |
dc.identifier.citation | Leukemia, 2022, v. 36, p. 1990-2001 | - |
dc.identifier.issn | 0887-6924 | - |
dc.identifier.uri | http://hdl.handle.net/10722/338944 | - |
dc.description.abstract | <p>Gain-of-function kinase mutations are common in AML and usually portend an inferior prognosis. We reported a novel mechanism whereby kinase mutants induced intracellular alkalization characteristic in oncogenesis. Thirteen kinases were found to activate sodium/hydrogen exchanger (NHE1) in normal hematopoietic progenitors, of which FLT3-ITD, KRAS<sup>G12D</sup>, and BTK phosphorylated NHE1 maintained alkaline intracellular pH (pHi) and supported survival of AML cells. Primary AML samples with kinase mutations also showed increased NHE1 phosphorylation and evidence of NHE1 addiction. Amiloride enhanced anti-leukemic effects and intracellular distribution of kinase inhibitors and chemotherapy. Co-inhibition of NHE1 and kinase synergistically acidified pHi in leukemia and inhibited its growth in vivo. Plasma from patients taking amiloride for diuresis reduced pHi of leukemia and enhanced cytotoxic effects of kinase inhibitors and chemotherapy in vitro. NHE1-mediated intracellular alkalization played a key pathogenetic role in transmitting the proliferative signal from mutated-kinase and could be exploited for therapeutic intervention in AML.</p> | - |
dc.language | eng | - |
dc.publisher | Springer Nature [academic journals on nature.com] | - |
dc.relation.ispartof | Leukemia | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.title | Regulation of proton partitioning in kinase-activating acute myeloid leukemia and its therapeutic implication | - |
dc.type | Article | - |
dc.identifier.doi | 10.1038/s41375-022-01606-0 | - |
dc.identifier.scopus | eid_2-s2.0-85130800255 | - |
dc.identifier.volume | 36 | - |
dc.identifier.spage | 1990 | - |
dc.identifier.epage | 2001 | - |
dc.identifier.eissn | 1476-5551 | - |
dc.identifier.isi | WOS:000805485900002 | - |
dc.identifier.issnl | 0887-6924 | - |